Clinical Topics
-
Is early-onset cancer an emerging global epidemic? -
Cost paramount when choosing metastatic breast cancer treatment -
Genetic tests create treatment opportunities and confusion for breast cancer patients -
Time to cancer diagnoses in U.S. averages 5 months -
Single Institution Retrospective Review of Patterns of Care and Disease Presentation in Female Veterans With Breast Cancer During the COVID-19 Pandemic
Digital Edition
Multimedia
Conference Coverage
-
Cannabis in Cancer: What Oncologists and Patients Should Know -
Identifying Barriers in Germline Genetic Testing Referrals for Breast Cancer: A Single-Center Experience -
Asynchronous Bilateral Breast Cancer in a Male Patient -
National Tele-Oncology High-Risk Breast Clinic Program -
Circulating Tumor DNA Hints at BC Recurrence Risk -
Eribulin Similar to Taxane When Paired With Dual HER2 Blockade in BC -
Clinical Controversy: Standard Dose or Baby TAM for Breast Cancer Prevention? -
MUC-1 vaccine associated with notable overall survival rates in breast cancer -
Platinum Add-On Improves Survival in Early TNBC -
One Patient Changed This Oncologist’s View of Hope. Here’s How.
Question 1 of 5
